Profilo
Dror Mevorach was the founder of Enlivex Therapeutics Ltd. (2005) as Chief Scientific & Medical Officer.
Dr. Mevorach was the founder of Enlivex Therapeutics Ltd. (2009) as Chief Scientific & Medical Officer.
Dr. Mevorach is currently the Chairman-Medicine at Hadassah University Hospital.
Dr. Mevorach holds a doctorate from Technion-Israel Institute of Technology.
Posizioni attive di Dror Mevorach
| Società | Posizione | Inizio |
|---|---|---|
Hadassah University Hospital
Hadassah University Hospital Hospital/Nursing ManagementHealth Services Operates hospitals and universities | Corporate Officer/Principal | - |
Precedenti posizioni note di Dror Mevorach
| Società | Posizione | Fine |
|---|---|---|
| ENLIVEX LTD. | Fondatore | - |
Enlivex Therapeutics Ltd. /Old/
Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Fondatore | - |
Formazione di Dror Mevorach
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Technion-Israel Institute of Technology
Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hadassah University Hospital
Hadassah University Hospital Hospital/Nursing ManagementHealth Services Operates hospitals and universities | Health Services |
Enlivex Therapeutics Ltd. /Old/
Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
















